Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / ADR
-
Number of holders
-
808
-
Total 13F shares, excl. options
-
301,924,050
-
Shares change
-
+5,338,077
-
Total reported value, excl. options
-
$11,117,499,712
-
Value change
-
+$193,375,712
-
Put/Call ratio
-
95%
-
Number of buys
-
297
-
Number of sells
-
450
-
Price
-
$36.80
Institutional Holders of GLAXOSMITHKLINE PLC - ADR (GSK) as of Q4 2020
As of 31 Dec 2020 GLAXOSMITHKLINE PLC - ADR (GSK) had 808 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 301,924,050 shares of stock of the company.
Largest 10 holders included Dodge & Cox, FMR LLC, Capital International Investors, PRICE T ROWE ASSOCIATES INC /MD/, Fisher Asset Management, LLC, ROYAL BANK OF CANADA, RENAISSANCE TECHNOLOGIES LLC, HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC, STATE STREET CORP, and Black Creek Investment Management Inc..
This table shows 808 institutional shareholders of the security as of 31 Dec 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.